"The African Genome Variation project, a key endeavour of the APCDR, will be an important resource for Africa researchers." says Dr Manjinder Sandhu, lead investigator from Wellcome Trust Sanger Institute and the University of Cambridge. "This will allow researchers to understand patterns of genetic diversity within sub-Saharan populations, as well as providing a global resource for genomic studies of diseases in Africa. If we want to have lasting benefits, the APCDR must provide mechanisms and infrastructure to share research resources, training and support with the next generation of researchers and scientific leaders in Africa."
"Understanding the cause and determinants of these diseases in sub-Saharan Africa is a fundamental step in developing strategies for diseases management and control," says Professor Pontiano Kaleebu, lead investigator from the MRC/UVRI Uganda Research Unit on AIDS. "In the context of epidemiological transition and the complex relation between risk factors for chronic infection and non-communicable disease, an integrated approach to our research is essential."
"For countries in sub-Saharan Africa to benefit from future progress in non-communicable disease research and genomics, there is a need to strengthen research capacity, training and collaboration across the region to ensure researchers can play a full part," says Professor Jean Claude Mbanya, lead investigator from the University of Yaounde, Cameroon. "This initiative will play an important role in piecing together the puzzle of non-communicable disease in Africa."
"The MRC is pleased to support such an innovative strategic partnership between UK scientists and centres of research excellence in sub-Saharan Afri
|Contact: Aileen Sheehy|
Wellcome Trust Sanger Institute